<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>CD34(+) bone marrow blasts from high-risk <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) patients as well as <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patient-derived cell lines (P39 and MOLM13) constitutively activate the nuclear factor-kappaB (NF-kappaB) pathway and undergo <z:mpath ids='MPATH_3'>apoptosis</z:mpath> when NF-kappaB is inhibited </plain></SENT>
<SENT sid="1" pm="."><plain>Here, we show that the combination of conventional chemotherapeutic agents (<z:chebi fb="0" ids="41977">daunorubicin</z:chebi>, <z:chebi fb="0" ids="50729">mitoxantrone</z:chebi>, <z:chebi fb="0" ids="2038">5-azacytidine</z:chebi> or <z:chebi fb="0" ids="27656">camptothecin</z:chebi>) with the NF-kappaB inhibitor BAY11-7082 did not yield a synergistic cytotoxicity </plain></SENT>
<SENT sid="2" pm="."><plain>In contrast, BAY11-7082 (which targets the NF-kappaB-activating I-kappaB kinase (IKK) complex) or knockdown of essential components of the NF-kappaB system (such as the IKK1 and IKK2 subunits of the IKK complex and the p65 subunit of NF-kappaB), by small interfering <z:chebi fb="40" ids="33697">RNAs</z:chebi> sensitized <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> cell lines to starvation-induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="3" pm="."><plain>The combination of BAY11-7082 and nutrient <z:mpath ids='MPATH_63'>depletion</z:mpath> synergistically killed the <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) cell line U937 as well as primary CD34(+) bone marrow blasts from <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> and high-risk <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients </plain></SENT>
<SENT sid="4" pm="."><plain>The synergistic killing by BAY11-7082, combined with nutrient <z:mpath ids='MPATH_63'>depletion</z:mpath>, led to cell <z:hpo ids='HP_0011420'>death</z:hpo> accompanied by <z:hpo ids='HP_0000001'>all</z:hpo> hallmarks of <z:mpath ids='MPATH_3'>apoptosis</z:mpath>, including an early loss of the <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> transmembrane potential, the release of <z:chebi fb="1" ids="18070">cytochrome c</z:chebi> and <z:mpath ids='MPATH_3'>apoptosis</z:mpath>-inducing factor (AIF) from mitochondria, activation of caspase-3, phosphatidylserine exposure on the plasma membrane surface and nuclear chromatin condensation </plain></SENT>
<SENT sid="5" pm="."><plain>Transmission electron microscopy revealed the presence of numerous <z:hpo ids='HP_0003736'>autophagic vacuoles</z:hpo> in the cytoplasm before cells underwent nuclear <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="6" pm="."><plain>Nonetheless, cell <z:hpo ids='HP_0011420'>death</z:hpo> was neither inhibited by the pan-caspase inhibitor z-VAD-fmk nor by knockdown of AIF or of essential components of the autophagy pathway (ATG5, ATG6/Beclin-1, ATG10, ATG12) </plain></SENT>
<SENT sid="7" pm="."><plain>In contrast, external supply of <z:chebi fb="105" ids="17234">glucose</z:chebi>, insulin or insulin-like growth factor-I could retard the cell <z:hpo ids='HP_0011420'>death</z:hpo> induced by BAY11-7082 combined with starvation </plain></SENT>
<SENT sid="8" pm="."><plain>These results suggest that in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> cells, NF-kappaB inhibition can precipitate a bioenergetic crisis that leads to an autophagic stress response followed by apoptotic cell <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
</text></document>